All Stocks/Technology/AKTS

Aktis Oncology, Inc.

AKTS
TechnologyCommunication Equipment Website
Ask about AKTSAI research agent
Alpha Score BreakdownHow it works →

Alpha Score of 72 reflects strong overall profile with moderate momentum, strong value, strong quality. Based on 3 of 4 signals — score is capped at 90 until remaining data ingests.

Momentum
50
Weak
Value
96
Strong
Quality
100
Strong
Sentiment
no data
Key StatisticsUpdated Apr 15
P/E Ratio
6.28
Forward P/E
PEG Ratio
EPS (TTM)
2.84
Dividend Yield
Beta
Revenue (TTM)
Net Margin
ROE
Debt / Equity
52W High
$22.40
52W Low
$0.00
About Aktis Oncology, Inc.

Akoustis Technologies Inc. is a technology company specializing in the design, development, manufacture, and sale of radio frequency (RF) filter products for the wireless industry across the Americas, Asia, Europe, and other international markets. It leverages proprietary bulk acoustic wave (BAW) technology, including its microelectromechanical system (MEMS)-based XBAW manufacturing process, to produce high-performance filters optimized for high power, high frequency, and wide bandwidth applications. The company operates through two primary segments: Fabrication Services, which offers engineering review and backend packaging services, and RF Filters, focused on amplifier and filter product sales. Its solutions serve critical applications in smartphones, tablets, cellular infrastructure equipment, Wi-Fi customer premise equipment, and military and defense systems. Akoustis Technologies Inc. also provides complementary products such as surface acoustic wave resonators, crystal resonators and oscillators, ceramic products, and back-end semiconductor supply chain services. Headquartered in Huntersville, North Carolina, the company plays a specialized role in advancing RF front-end modules for next-generation wireless connectivity.

CEO
Mr. Kamran Cheema
Employees
117
Quick Facts
Exchange
SectorTechnology
IndustryCommunication Equipment
Market Cap
Key Dates

Earnings calendar coming soon. Subscribe to get notified when AKTS reports next.

Get earnings alerts →